Treatment of Relapses in ANCA-Associated Vasculitis

Diagnostic and therapeutic advances for ANCA-associated vasculitis have improved 1-year survival, and ANCA-associated vasculitis is now considered a chronic relapsing disease. Avoiding long-term treatment toxicity and preventing, detecting, and treating relapses early are keys to improving quality